Neuropsychiatrist Stresses Importance of Depression-MS Link
May 6th 2022Anthony Feinstein, Ph.D., of the University of Toronto, author of a new book about multiple sclerosis and mood, says clinicians and patients need to pay more attention to the effects that depression has on the cognitive abilities of patients with the disease.
Read More
MS Patients Warmed To Telehealth During the COVID-19 Pandemic
March 8th 2022Analysis of answers to online survey shows that telehealth use is high among people with multiple sclerosis (MS) amid the COVID-19 pandemic. Telehealth may be an appealing option for patients with MS who have physical impairments that make traveling to in-person appointments difficult.
Read More
Study Finding: Discontinuation of Natalizumab for Pregnancy Carries Risk of Disability
February 3rd 2022German research team finds that 11% of those who quit the drug for pregnancy had “clinically meaningful disability” one-year postpartum. They don’t advise against quitting the drug but say their findings suggest that patients should be informed of the risk.
Read More
Thomas P. Leist, MD, PhD, a neurologist and professor of Multiple Sclerosis at Jefferson University Hospitals, is the latest guest featured on MHE Talks: Improving Patient Access podcast. In this episode, Thomas spoke with Peter Wehrwein, senior editor of Managed Healthcare Executive, about accessing care amongst patients with MS through therapies, health insurance barriers, options of step therapy and more.
Read More
Adherence to Disease-Modifying Therapies in Pregnant MS Patients Can Reduce Hospitalization
March 2nd 2021Results from research analyzing data of females with multiple sclerosis (MS) who became pregnant, and the impact of adherence to their disease-modifying therapies (DMTs) on hospital utilization and cost, were recently released by AllianceRx Walgreens Prime.
Read More